UBS downgrades Millicom stock rating to neutral on valuation By Investing.com

UBS downgraded Millicom International Cellular to Neutral from Buy and raised its price target to $90 from $87.50, citing that most of the M&A-driven rerating and free cash flow upside are already priced in. The stock trades at $85.84, near its 52-week high of $86.93, after a 157% one-year rally and a 61% year-to-date gain, but UBS sees near-term execution risk around Coltel restructuring and Colombia capex. First-quarter 2026 EPS missed sharply at $0.65 versus $1.44 expected, even as revenue slightly beat at $1.99 billion versus $1.98 billion.

Analysis

The market is now paying up for a rerating that was driven by corporate action and balance-sheet simplification, but the next leg is harder: this becomes a pure execution story, and execution stories in frontier/emerging telecoms tend to decay quickly once the easy financial engineering is recognized. The key second-order issue is that the valuation premium is now high enough that any capex slippage, FX wobble, or integration hiccup can compress the multiple faster than management can grow EBITDA, especially given the stock’s recent run.

The earnings profile matters more than the headline miss suggests: the gap between consensus and realized EPS indicates that near-term cash conversion is more fragile than the market had assumed. If capex is stepping up to fund network expansion, free cash flow can look “optically strong” while true residual equity cash flow gets crowded out for several quarters; that is exactly when re-rating names tend to underperform peers despite stable revenue. The risk/reward has shifted from upside optionality to downside asymmetry.

The contrarian angle is that the market may be underestimating how quickly the premium multiple can normalize if the company simply grows into its current valuation more slowly than expected. In that sense, the stock is vulnerable to a de-rating even without outright fundamental deterioration. The more interesting beneficiary on a relative basis may be a cheaper regional telecom or EM cash-flow compounder that hasn’t yet fully priced in integration benefits, because capital is likely to rotate toward similar names with cleaner execution and lower valuation risk.

Key Decisions for Investors

• Trim or short TIGO on strength over the next 1-4 weeks; risk/reward favors a 10-15% downside re-rating if the market decides the M&A/Fcf story is fully priced.
• Use TIGO as a pair-trade short against a lower-multiple Latin American telecom or EM cash-flow name over 3-6 months; the thesis is multiple compression, not outright business collapse.
• If long TIGO already, hedge with near-dated puts into the next earnings/capex update window; execution risk is highest over the next 1-2 quarters while integration and Colombia capex ramp are still front-of-mind.
• Do not add on the basis of the earnings beat/miss mix alone; wait for proof that equity FCF can stay near guidance after capex ramps, otherwise the premium valuation remains vulnerable.
• For relative-value portfolios, rotate toward cheaper telecoms with cleaner capital intensity and less integration risk; the setup favors names where the market has not yet fully priced in margin and cash-flow improvement.